Research

Hormonal

Exenatide once weekly improves glycemic control (A1C and FPG) and cardiovascular risk markers (SBP, LDL-C, triglycerides) independently of weight loss, although the magnitude of improvement is greater in patients with higher weight loss.

If you have Type 2 Diabetes, Exenatide once weekly will lower your blood sugar (A1C) and improve heart health markers even if you don't lose weight. However, you will get the biggest benefits if you do lose weight. Be aware that those who lose the most weight are more likely to experience nausea or hypoglycemia, especially if you are also taking sulfonylureas. Most people tolerate the injection well.

GoodQualifiesHIGH confidence
Exenatide once weekly improved glycemic parameters independent of weight change, although the magnitude of improvement increased with increasing weight loss.
Lawrence Blonde et al. · Cardiovascular Diabetology · 2015

Why this rating

Pooled analysis of 8 randomized controlled trials (N=1830) provides robust statistical power, though it is an observational analysis of pooled data rather than a single RCT.

Source

Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes

Lawrence Blonde et al. · Cardiovascular Diabetology · 2015

DOI 10.1186/s12933-014-0171-2

Meta-analysis · 8 studiesCited 73×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →